Story perspectives
Health Groups Warn UK-US Drug Deal Costs £44.7bn, 229k Lives
7/10/2026
1 of 1
Story summary
- Nineteen health organisations warn the UK-US medicines trade deal will divert £44.7 billion from NHS services by 2036, creating 229,000 excess deaths.
- They have asked Andy Burnham, soon-to-be Labour leader, to scrap the agreement signed in December.
- Critics say the deal was secured after pressure from U.S. President Donald Trump to raise drug prices, prioritising pharmaceutical profits over patient care.
